α1a-adrenergic receptor induces activation of extracellular signal-regulated kinase 1/2 through endocytic pathway

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Liu, Fei ^a   He, Kangmin ^a   Yang, Xinxing ^b   Xu, Ning ^a   Liang, Zhangyi ^b   Xu, Ming ^a   Zhao, Xinsheng ^b   Han, Qide ^a   Zhang, Youyi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; CYTOCHALASIN D; DYNAMIN; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RAF PROTEIN; ALPHA 1 ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 6; PHENYLEPHRINE;

ACTIN FILAMENT; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; INTERNALIZATION; LOW TEMPERATURE; MUTATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; CELL LINE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; BLOTTING, WESTERN; CELL LINE; ENDOCYTOSIS; HUMANS; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 6; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

EID: 79959599182     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021520     Document Type: Article

References (49)

1. Terzic A, Puceat M, Vassort G, Vogel SM, (1993) Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev 45: 147-75.
2. Docherty JR, (2010) Subtypes of functional alpha1-adrenoceptor. Cell Mol Life Sci 67: 405-17.
3. Zhang YY, Xu KM, Han C, (1999) Alpha(1)-adrenoceptor subtypes mediating inotropic responses in rat heart. J Pharmacol Exp Ther 291: 829-36.
4. Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, et al. (2006) Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27: 330-7.
5. Flechtner-Mors M, Jenkinson CP, Alt A, Biesalski HK, Adler G, et al. (2004) Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity. Obes Res 12: 612-20.
6. Iaccarino G, Keys JR, Rapacciuolo A, Shotwell KF, Lefkowitz RJ, et al. (2001) Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol 38: 534-40.
7. Lin F, Owens WA, Chen S, Stevens ME, Kesteven S, et al. (2001) Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res 89: 343-50.
8. Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, et al. (2006) Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res 71: 735-43.
9. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, et al. (2000) Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86: 692-9.
10. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, et al. (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-50.
11. Flesch M, Margulies KB, Mochmann HC, Engel D, Sivasubramanian N, et al. (2001) Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 104: 2273-6.
12. Huang Y, Wright CD, Merkwan CL, Baye NL, Liang Q, et al. (2007) An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 115: 763-72.
13. Michelotti GA, Price DT, Schwinn DA, (2000) Alpha 1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88: 281-309.
14. Wu D, Katz A, Lee CH, Simon MI, (1992) Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J Biol Chem 267: 25798-802.
15. Koshimizu TA, Tanoue A, Hirasawa A, Yamauchi J, Tsujimoto G, (2003) Recent advances in alpha1-adrenoceptor pharmacology. Pharmacol Ther 98: 235-44.
16. Copik AJ, Ma C, Kosaka A, Sahdeo S, Trane A, et al. (2009) Facilitatory interplay in alpha 1a and beta 2 adrenoceptor function reveals a non-Gq signaling mode: implications for diversification of intracellular signal transduction. Mol Pharmacol 75: 713-28.
17. Vieira AV, Lamaze C, Schmid SL, (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274: 2086-9.
18. Daaka Y, Luttrell LM, Ahn S, Della RGJ, Ferguson SS, et al. (1998) Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem 273: 685-8.
19. Calebiro D, Nikolaev VO, Persani L, Lohse MJ, (2010) Signaling by internalized G-protein-coupled receptors. Trends Pharmacol Sci 31: 221-8.
20. Bliss SP, Navratil AM, Breed M, Skinner DC, Clay CM, et al. (2007) Signaling complexes associated with the type I gonadotropin-releasing hormone (GnRH) receptor: colocalization of extracellularly regulated kinase 2 and GnRH receptor within membrane rafts. Mol Endocrinol 21: 538-49.
21. Liang ZY, Xu N, Guan YH, Xu M, He QH, et al. (2007) The transport of alpha(1A)-adrenergic receptor with 33-nm step size in live cells. Biochem Biophys Res Commun 353: 231-7.
22. Puthenveedu MA, von ZM, (2006) Cargo regulates clathrin-coated pit dynamics. Cell 127: 113-24.
23. Gong K, Li Z, Xu M, Du J, Lv Z, et al. (2008) A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J Biol Chem 283: 29028-36.
24. Pelkmans L, Puntener D, Helenius A, (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296: 535-9.
25. Kohlhaas SL, Craxton A, Sun XM, Pinkoski MJ, Cohen GM, (2007) Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem 282: 12831-41.
26. Muratoglu SC, Mikhailenko I, Newton C, Migliorini M, Strickland DK, (2010) Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway. J Biol Chem 285: 14308-17.
27. Damke H, Baba T, Warnock DE, Schmid SL, (1994) Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 127: 915-34.
28. Bayer N, Schober D, Huttinger M, Blaas D, Fuchs R, (2001) Inhibition of clathrin-dependent endocytosis has multiple effects on human rhinovirus serotype 2 cell entry. J Biol Chem 276: 3952-62.
29. Yamada H, Padilla-Parra S, Park SJ, Itoh T, Chaineau M, et al. (2009) Dynamic interaction of amphiphysin with N-WASP regulates actin assembly. J Biol Chem 284: 34244-56.
30. O-Uchi J, Sasaki H, Morimoto S, Kusakari Y, Shinji H, et al. (2008) Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel. Circ Res 102: 1378-88.
31. Xu N, Liang ZY, Xu M, Guan YH, He QH, et al. (2007) Real-time detection of alpha1A-AR movement stimulated by phenylephrine in single living cells. Acta Pharmacol Sin 28: 796-802.
32. Mehta AD, Rock RS, Rief M, Spudich JA, Mooseker MS, et al. (1999) Myosin-V is a processive actin-based motor. Nature 400: 590-3.
33. Rief M, Rock RS, Mehta AD, Mooseker MS, Cheney RE, et al. (2000) Myosin-V stepping kinetics: a molecular model for processivity. Proc Natl Acad Sci U S A 97: 9482-6.
34. Yildiz A, Forkey JN, McKinney SA, Ha T, Goldman YE, et al. (2003) Myosin V walks hand-over-hand: single fluorophore imaging with 1.5-nm localization. Science 300: 2061-5.
35. Mallik R, Carter BC, Lex SA, King SJ, Gross SP, (2004) Cytoplasmic dynein functions as a gear in response to load. Nature 427: 649-52.
36. Xiao L, Pimental DR, Amin JK, Singh K, Sawyer DB, et al. (2001) MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 779-87.
37. Rohini A, Agrawal N, Koyani CN, Singh R, (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61: 269-80.
38. Hu ZW, Shi XY, Lin RZ, Hoffman BB, (1999) Contrasting signaling pathways of alpha1A- and alpha1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells. Mol Endocrinol 13: 3-14.
39. Toews ML, Prinster SC, Schulte NA, (2003) Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability. Life Sci 74: 379-89.
40. Hawes BE, van BT, Koch WJ, Luttrell LM, Lefkowitz RJ, (1995) Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 270: 17148-53.
41. Berts A, Zhong H, Minneman KP, (1999) No role for Ca++ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol 55: 296-303.
42. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK, (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483-510.
43. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, et al. (2000) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-81.
44. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, et al. (2000) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci U S A 97: 11086-91.
45. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, et al. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A 98: 2449-54.
46. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, et al. (2003) The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278: 6258-67.
47. Stanasila L, Abuin L, Dey J, Cotecchia S, (2008) Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50. Mol Pharmacol 74: 562-73.
48. Slessareva JE, Routt SM, Temple B, Bankaitis VA, Dohlman HG, (2006) Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome. Cell 126: 191-203.
49. Abe M, Setoguchi Y, Tanaka T, Awano W, Takahashi K, et al. (2009) Membrane protein location-dependent regulation by PI3K (III) and rabenosyn-5 in Drosophila wing cells. PLoS One 4: e7306.